Back to User profile » Prof. Dr. Ulrich Mrowietz

Papers published by Prof. Dr. Ulrich Mrowietz:


Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study

Mrowietz U, Sommer R, Reguiai Z, Gerdes S, Daudén E, Weger W, Maul JT, Naldi L, Ghislain PD, Laws PM, De Jong EMGJ, Mburu S, Koscielny V, Massana E, Sapena V, Domenech A, Kasujee I, Augustin M

Psoriasis: Targets and Therapy 2026, 16:590189

Published Date: 12 May 2026

Prevalence of Genital Psoriasis and Its Impact on Patients’ Sexual Life in Routine Care: Epidemiologic Survey in Germany

Janke TM, Sorbe C, Sommer R, Bickert T, Mrowietz U, Gomis-Kleindienst S, Schild M, Lohmann K, Augustin M

Psoriasis: Targets and Therapy 2026, 16:516803

Published Date: 21 January 2026

Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study

Graphical Abstract of Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study

Mrowietz U, Sommer R, Gerdes S, Reguiai Z, Weger W, Daudén E, Maul JT, Ghislain PD, Laws PM, Naldi L, De Jong E, Mburu S, Koscielny V, Massana E, Domenech A, Gaarn du Jardin K, Kasujee I, Augustin M

Psoriasis: Targets and Therapy 2025, 15:243-259

Published Date: 28 June 2025

Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries

Valencia López MJ, Stephan B, Meineke A, Wolf S, Thaci D, Mrowietz U, Andrees V, Rustenbach SJ, Reich K, Thalmann L, Bogena H, Staubach P, von Kiedrowski RM, Augustin M

Psoriasis: Targets and Therapy 2024, 14:29-38

Published Date: 14 May 2024